| Product Code: ETC6757043 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China mRNA Vaccine and Therapeutics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 China mRNA Vaccine and Therapeutics Market - Industry Life Cycle |
3.4 China mRNA Vaccine and Therapeutics Market - Porter's Five Forces |
3.5 China mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 China mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 China mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 China mRNA Vaccine and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government support and investments in mRNA vaccine and therapeutics research and development. |
4.2.2 Rising prevalence of infectious diseases and chronic conditions, driving the demand for innovative treatment options. |
4.2.3 Technological advancements in mRNA technology, making it more efficient and cost-effective. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for mRNA vaccines and therapeutics in China. |
4.3.2 Limited public awareness and acceptance of mRNA technology in healthcare. |
5 China mRNA Vaccine and Therapeutics Market Trends |
6 China mRNA Vaccine and Therapeutics Market, By Types |
6.1 China mRNA Vaccine and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021- 2031F |
6.1.4 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021- 2031F |
6.2 China mRNA Vaccine and Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.2.5 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.3 China mRNA Vaccine and Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.3.3 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.5 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.4 China mRNA Vaccine and Therapeutics Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Research Laboratories and Organizations, 2021- 2031F |
6.4.3 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.5 China mRNA Vaccine and Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 China mRNA Vaccine and Therapeutics Market Import-Export Trade Statistics |
7.1 China mRNA Vaccine and Therapeutics Market Export to Major Countries |
7.2 China mRNA Vaccine and Therapeutics Market Imports from Major Countries |
8 China mRNA Vaccine and Therapeutics Market Key Performance Indicators |
8.1 Research and development (RD) investment in mRNA vaccine and therapeutics. |
8.2 Number of clinical trials conducted for mRNA-based treatments in China. |
8.3 Adoption rate of mRNA vaccines and therapeutics by healthcare providers in China. |
9 China mRNA Vaccine and Therapeutics Market - Opportunity Assessment |
9.1 China mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 China mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 China mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
10 China mRNA Vaccine and Therapeutics Market - Competitive Landscape |
10.1 China mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 China mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here